In the SURMOUNT-4 trial, participants who discontinued tirzepatide regained much of the weight they had initially lost (Cornell Chronicle)
Most patients (97%) were treated with one or more glucose lowering medications at baseline: metformin (76%), insulin (51%), SGLT-2 inhibitor (27%), sulfonylurea (29%), and DPP-4 inhibitor (23%)
These soften stool without forcing unnatural contractions
Our Address: 7009 Dr Phillips Blvd Suite 240 Orlando, FL 32819 Phone: (407) 804-5200 Book an Appointment in East Orlando
Visible results often appear gradually over several weeks or months depending on the frequency of treatments and the individual metabolism of the patient
Potency, purity, and consistency can vary between compounding pharmacies and even between batches